Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Guardant Health Stock Just Crashed 10%


Shares of precision medicine company Guardant Health (NASDAQ: GH), which specializes in liquid biopsies to test for cancer, fell 10.6% through 10:05 a.m. ET Monday morning.

Monday was the first trading day in which investors got to react to a Guardant announcement late Friday, that it plans to sell stock and raise $400 million in new cash to fund its operations.

Guardant's announcement came in the form of an 8-K filing with the Securities and Exchange Commission (SEC). "From time to time at its sole discretion," said Guardant, it "may offer and sell (emphasis added) up to $400.0 million" in new shares at market prices.

Continue reading


Source Fool.com

Like: 0
GH
Share

Comments